scholarly article | Q13442814 |
review article | Q7318358 |
P2093 | author name string | Maya Simionescu | |
Ileana Manduteanu | |||
P2860 | cites work | P-Selectin- and CD63-Exposing Platelet Microparticles Reflect Platelet Activation in Peripheral Arterial Disease and Myocardial Infarction | Q62977663 |
Endothelial CD81 is a marker of early human atherosclerotic plaques and facilitates monocyte adhesion | Q63915830 | ||
Plasminogen Activator Expression in Human Atherosclerotic Lesions | Q72049376 | ||
Intimal thickenings of human aorta contain modified reassembled lipoproteins | Q72290595 | ||
The role of mast cells in atherosclerosis | Q73711722 | ||
Differential chemokine receptor expression and function in human monocyte subpopulations | Q73792772 | ||
Early inflammatory-immunological lesions in juvenile atherosclerosis from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY)-study | Q77647851 | ||
Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis | Q77859042 | ||
A comparative study of neovascularisation in atherosclerotic plaques using CD31, CD105 and TGF beta 1 | Q79374734 | ||
Atherogenic lipids induce adhesion of human coronary artery smooth muscle cells to macrophages by up-regulating chemokine CX3CL1 on smooth muscle cells in a TNFalpha-NFkappaB-dependent manner | Q80210245 | ||
CD14+CD16+ monocytes in coronary artery disease and their relationship to serum TNF-alpha levels | Q80371547 | ||
Biomechanical forces in atherosclerosis-resistant vascular regions regulate endothelial redox balance via phosphoinositol 3-kinase/Akt-dependent activation of Nrf2 | Q80731370 | ||
Immunoliposomes directed toward VCAM-1 interact specifically with activated endothelial cells--a potential tool for specific drug delivery | Q81024877 | ||
Monocytes in atherosclerosis: subsets and functions | Q22251045 | ||
MicroRNAs: target recognition and regulatory functions | Q24609584 | ||
Fractalkine in vascular biology: from basic research to clinical disease | Q28206445 | ||
Cloning of an immunoglobulin family adhesion molecule selectively expressed by endothelial cells | Q28208656 | ||
Fine-tuning leukocyte responses: towards a chemokine 'interactome' | Q28238676 | ||
Monocyte and macrophage heterogeneity | Q29547438 | ||
Structure and function of matrix metalloproteinases and TIMPs | Q30014818 | ||
Interaction of vascular smooth muscle cells and monocytes by soluble factors synergistically enhances IL-6 and MCP-1 production | Q30319159 | ||
Role of smooth muscle cells in the initiation and early progression of atherosclerosis | Q30438867 | ||
Distinctive expression of chemokines and transforming growth factor-beta signaling in human arterial endothelium during atherosclerosis | Q33288811 | ||
Low numbers of FOXP3 positive regulatory T cells are present in all developmental stages of human atherosclerotic lesions | Q33294845 | ||
The impact of macrophage insulin resistance on advanced atherosclerotic plaque progression | Q33586616 | ||
Dendritic cells in atherosclerotic disease | Q33651897 | ||
Inflammation in atherosclerosis: from pathophysiology to practice | Q33709505 | ||
Insights into atherosclerosis using nanotechnology | Q33824820 | ||
Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions | Q33916802 | ||
Endothelial dysfunction, hemodynamic forces, and atherogenesis | Q33949677 | ||
Matrix metalloproteinase-10 effectively reduces infarct size in experimental stroke by enhancing fibrinolysis via a thrombin-activatable fibrinolysis inhibitor-mediated mechanism. | Q34079723 | ||
Nomenclature of monocytes and dendritic cells in blood. | Q34125860 | ||
The immune system in atherosclerosis | Q34164644 | ||
The role of junctional adhesion molecule-C (JAM-C) in oxidized LDL-mediated leukocyte recruitment | Q34651060 | ||
Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice | Q34789613 | ||
Dyslipidaemia in rheumatological autoimmune diseases | Q35029916 | ||
The NF-kappa B signal transduction pathway in aortic endothelial cells is primed for activation in regions predisposed to atherosclerotic lesion formation. | Q35193982 | ||
Site specificity of atherosclerosis: site-selective responses to atherosclerotic modulators | Q35578683 | ||
Localization of unesterified cholesterol in human atherosclerotic lesions. Demonstration of filipin-positive, oil-red-O-negative particles | Q35857850 | ||
Chemokines: key regulators of mononuclear cell recruitment in atherosclerotic vascular disease | Q35866628 | ||
Metalloproteinases in development and progression of vascular disease | Q36030425 | ||
Thematic review series: The immune system and atherogenesis. Cytokines affecting endothelial and smooth muscle cells in vascular disease. | Q36099980 | ||
Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates | Q36305029 | ||
A transmigratory cup in leukocyte diapedesis both through individual vascular endothelial cells and between them | Q36322724 | ||
Platelets in inflammation and atherogenesis. | Q36328825 | ||
C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients | Q36456535 | ||
The immune response in atherosclerosis: a double-edged sword | Q36508676 | ||
Investigation of the effect of Interleukin-1 receptor antagonist (IL-1ra) on markers of inflammation in non-ST elevation acute coronary syndromes (The MRC-ILA-HEART Study). | Q36532549 | ||
Coexisting proinflammatory and antioxidative endothelial transcription profiles in a disturbed flow region of the adult porcine aorta. | Q36602479 | ||
Implications of early structural-functional changes in the endothelium for vascular disease | Q36670301 | ||
IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis | Q36849075 | ||
Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: molecular, cellular, and vascular behavior | Q36864228 | ||
PECAM-1 is a critical mediator of atherosclerosis | Q36924371 | ||
Pathology of atherosclerosis and stenting | Q36934746 | ||
Endothelial transcriptome profiles in vivo in complex arterial flow fields | Q36989558 | ||
Macrophages: an elusive yet emerging therapeutic target of atherosclerosis. | Q37000623 | ||
Translating molecular discoveries into new therapies for atherosclerosis | Q37089723 | ||
Molecular and cellular mechanisms of the thrombotic complications of atherosclerosis | Q37173216 | ||
Metalloproteinase expression in monocytes and macrophages and its relationship to atherosclerotic plaque instability | Q37261160 | ||
Endothelial heterogeneity associated with regional athero-susceptibility and adaptation to disturbed blood flow in vivo | Q37280276 | ||
Macrophages heterogeneity in atherosclerosis - implications for therapy. | Q37294955 | ||
Inflammatory cytokines in vascular dysfunction and vascular disease | Q37315106 | ||
Immune and inflammatory mechanisms of atherosclerosis (*) | Q37325024 | ||
The LDL modification hypothesis of atherogenesis: an update | Q37326175 | ||
Differential associations between soluble cellular adhesion molecules and atherosclerosis in the Dallas Heart Study: a distinct role for soluble endothelial cell-selective adhesion molecule | Q37407759 | ||
Mast cells in atherogenesis: actions and reactions | Q37441281 | ||
Obesity, inflammation, and atherosclerosis | Q37462172 | ||
Platelet-derived microparticles and the potential of glycoprotein IIb/IIIa antagonists in treating acute coronary syndrome. | Q37479125 | ||
Circulating oxidized LDL: a biomarker and a pathogenic factor | Q37559201 | ||
Macrophage diversity and polarization in atherosclerosis: a question of balance | Q37583322 | ||
Treating inflammation in atherosclerotic cardiovascular disease: emerging therapies | Q37625670 | ||
Role of polymorphonuclear neutrophils in atherosclerosis: current state and future perspectives | Q37636654 | ||
New observations on the trafficking and diapedesis of monocytes | Q37649411 | ||
Therapeutic targeting of chemokine interactions in atherosclerosis | Q37684793 | ||
The vascular biology of atherosclerosis and imaging targets | Q37731750 | ||
Imaging atherosclerotic plaque inflammation by fluorodeoxyglucose with positron emission tomography: ready for prime time? | Q37761792 | ||
Microparticles: protagonists of a novel communication network for intercellular information exchange | Q37804649 | ||
Platelet–Leukocyte Interactions in Cardiovascular Disease and Beyond | Q37808902 | ||
Recent advances on the role of cytokines in atherosclerosis | Q37867358 | ||
An integrated approach for the mechanisms responsible for atherosclerotic plaque regression | Q38963714 | ||
Resistin up-regulates fractalkine expression in human endothelial cells: lack of additive effect with TNF-alpha | Q39863316 | ||
Soluble N-cadherin overexpression reduces features of atherosclerotic plaque instability | Q39999043 | ||
Influence of beta 1 integrin intracytoplasmic domains in the regulation of VLA-4-mediated adhesion of human T cells to VCAM-1 under flow conditions | Q40400382 | ||
Prelesional events in atherogenesis. Accumulation of extracellular cholesterol-rich liposomes in the arterial intima and cardiac valves of the hyperlipidemic rabbit | Q42528560 | ||
Chronic endoplasmic reticulum stress activates unfolded protein response in arterial endothelium in regions of susceptibility to atherosclerosis. | Q42559927 | ||
Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice | Q43489161 | ||
Shear stress activation of SREBP1 in endothelial cells is mediated by integrins | Q43852804 | ||
Different efflux pathways for high and low density lipoproteins from porcine aortic intima. | Q45057458 | ||
Involvement of JAM-A in mononuclear cell recruitment on inflamed or atherosclerotic endothelium: inhibition by soluble JAM-A. | Q45244813 | ||
Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation | Q45884595 | ||
Effect of depletion of monocytes/macrophages on early aortic valve lesion in experimental hyperlipidemia | Q46081397 | ||
Suppression of inflammatory signaling in monocytes from patients with coronary artery disease | Q46212544 | ||
Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL). | Q47945239 | ||
Neutrophils launch monocyte extravasation by release of granule proteins. | Q50324474 | ||
Platelets recruit human dendritic cells via Mac-1/JAM-C interaction and modulate dendritic cell function in vitro. | Q50335763 | ||
Smooth muscle cells in atherosclerosis originate from the local vessel wall and not circulating progenitor cells in ApoE knockout mice. | Q50713676 | ||
Comparison of vascular smooth muscle cell apoptosis and fibrous cap morphology in symptomatic and asymptomatic carotid artery disease. | Q52548882 | ||
Fractalkine upregulates intercellular adhesion molecule-1 in endothelial cells through CX3CR1 and the Jak Stat5 pathway. | Q53526299 | ||
Nuclear factor of activated T cells mediates oxidised LDL-induced calcification of vascular smooth muscle cells. | Q54363109 | ||
Prelesional events in atherogenesis. Changes induced by hypercholesterolemia in the cell surface chemistry of arterial endothelium and blood monocytes, in rabbit. | Q54408809 | ||
The potential role of resistin in atherogenesis. | Q54643707 | ||
Circulating bone marrow cells can contribute to neointimal formation | Q57221091 | ||
Endothelial tetraspanin microdomains regulate leukocyte firm adhesion during extravasation | Q57282535 | ||
Importance of Junctional Adhesion Molecule-A for Neointimal Lesion Formation and Infiltration in Atherosclerosis-Prone Mice | Q57574599 | ||
Immaturity of microvessels in haemorrhagic plaques is associated with proteolytic degradation of angiogenic factors | Q59315353 | ||
Topology of protease activities reflects atherothrombotic plaque complexity | Q59315361 | ||
P433 | issue | 9 | |
P921 | main subject | lipid metabolism disorder | Q1476525 |
atherosclerosis | Q12252367 | ||
inflammation | Q101991 | ||
cardiovascular disease | Q389735 | ||
dyslipidemia | Q66291209 | ||
P304 | page(s) | 1978-1990 | |
P577 | publication date | 2012-09-01 | |
P1433 | published in | Journal of Cellular and Molecular Medicine | Q1524063 |
P1476 | title | Inflammation in atherosclerosis: a cause or a result of vascular disorders? | |
P478 | volume | 16 |
Q92540743 | A Critical Role of PCSK9 in Mediating IL-17-Producing T Cell Responses in Hyperlipidemia |
Q38160221 | A Review of the Pharmacological Effects of the Dried Root of Polygonum cuspidatum (Hu Zhang) and Its Constituents |
Q98567781 | Anti-inflammatory effects of sodium-glucose co-transporter 2 inhibitors on atherosclerosis |
Q34909149 | Antiatherosclerotic effect of korean red ginseng extract involves regulator of g-protein signaling 5. |
Q92889499 | Aronia berry extract inhibits TNF-α-induced vascular endothelial inflammation through the regulation of STAT3 |
Q38846131 | Association between baseline vitamin D metabolite levels and long-term cardiovascular events in patients with rheumatoid arthritis from the CIMESTRA trial: protocol for a cohort study with patient-record evaluated outcomes |
Q34011460 | Association of chemerin with oxidative stress, inflammation and classical adipokines in non-diabetic obese patients |
Q54957811 | Cardiovascular Health Benefits of Specific Vegetable Types: A Narrative Review. |
Q28069923 | Cardiovascular disease and type 2 diabetes in evolutionary perspective: a critical role for helminths? |
Q42992047 | Combined treatment of hydroxytyrosol with carbon monoxide-releasing molecule-2 prevents TNF α-induced vascular endothelial cell dysfunction through NO production with subsequent NFκB inactivation. |
Q36223006 | Correlation of lifetime progress of atherosclerosis and morphologic markers of severity in humans: new tools for a more sensitive evaluation |
Q52606637 | Cruciferous and Total Vegetable Intakes Are Inversely Associated With Subclinical Atherosclerosis in Older Adult Women. |
Q41260650 | Dysfunctional high-density lipoproteins have distinct composition, diminished anti-inflammatory potential and discriminate acute coronary syndrome from stable coronary artery disease patients. |
Q48188092 | Epicardial fat thickness is associated with aortic intima-media thickness in patients without clinical manifestation of atherosclerotic cardiovascular disease |
Q49787949 | Ganglioside GM1 contributes to extracellular/intracellular regulation of insulin resistance, impairment of insulin signaling and down-stream eNOS activation, in human aortic endothelial cells after short- or long-term exposure to TNFα. |
Q64254072 | Gangliosides Contribute to Vascular Insulin Resistance |
Q36102976 | Hyperglycemia Determines Increased Specific MicroRNAs Levels in Sera and HDL of Acute Coronary Syndrome Patients and Stimulates MicroRNAs Production in Human Macrophages |
Q34943068 | Is butyrate the link between diet, intestinal microbiota and obesity-related metabolic diseases? |
Q91928211 | LDLR Gene Polymorphisms (rs5925 and rs1529729) Are Associated with Susceptibility to Coronary Artery Disease in a South Indian Population |
Q50934314 | Lipid Droplet Biogenesis and Function in the Endothelium. |
Q34744031 | Lipid regulators during atherogenesis: expression of LXR, PPAR, and SREBP mRNA in the human aorta. |
Q50096190 | LncRNAs in vascular biology and disease. |
Q37153809 | Loss of ADAMTS4 reduces high fat diet-induced atherosclerosis and enhances plaque stability in ApoE(-/-) mice. |
Q38989145 | Macrophage-mediated response to hypoxia in disease |
Q51054181 | Monocytes and smooth muscle cells cross-talk activates STAT3 and induces resistin and reactive oxygen species production [corrected]. |
Q37062847 | N,N-dimethylacetamide regulates the proinflammatory response associated with endotoxin and prevents preterm birth |
Q28539734 | Notoginsenoside R1 attenuates atherosclerotic lesions in ApoE deficient mouse model |
Q38865214 | Ox-LDL Upregulates IL-6 Expression by Enhancing NF-κB in an IGF2-Dependent Manner in THP-1 Macrophages |
Q41200749 | P-Selectin Targeted Dexamethasone-Loaded Lipid Nanoemulsions: A Novel Therapy to Reduce Vascular Inflammation. |
Q35631982 | Protective effects of isorhamnetin on apoptosis and inflammation in TNF-α-induced HUVECs injury. |
Q41171963 | Regulation of indoleamine 2,3-dioxygenase in primary human saphenous vein endothelial cells |
Q93116064 | Salusin-α levels are negatively correlated with diastolic blood pressure in children with obesity |
Q61448324 | Synergistic effects of liposomes encapsulating atorvastatin calcium and curcumin and targeting dysfunctional endothelial cells in reducing atherosclerosis |
Q54389261 | TNF-α promotes early atherosclerosis by increasing transcytosis of LDL across endothelial cells: crosstalk between NF-κB and PPAR-γ. |
Q38767234 | The Potential Therapeutic Application of Peptides and Peptidomimetics in Cardiovascular Disease |
Q50420098 | The peptide lycosin-I attenuates TNF-α-induced inflammation in human umbilical vein endothelial cells via IκB/NF-κB signaling pathway. |
Q37140378 | Total and differential white blood cell counts in late life predict 8-year incident stroke: the Honolulu Heart Program |
Q48219913 | Unraveling the Interaction of Aspirin, Ticagrelor, and Rosuvastatin on the Progression of Atherosclerosis and Inflammation in Diabetic Mice. |
Q33706352 | Urantide improves atherosclerosis by controlling C-reactive protein, monocyte chemotactic protein-1 and transforming growth factor-β expression in rats |